FTC PBM Prime Therapeutics to Pay $10 Million Antitrust Case Over Price-Fixing… Thomas Sullivan Jan 29, 2025 0 In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and Blue…
